Induction of anti-tumor immunity by trifunctional antibodies in patients with peritoneal carcinomatosis

Table 4 Restimulation and response

Patient	Increase of IFN-γ secreting T-lymphocytes	HAMA (ng/ml)	Chemotherapy after trAb therapy	Survival after trAb therapy (months)
A	+	801	-	1
B	+	230	+	21
C	-	30512	+	31
D	-	n.d.	-	4
E	+	7870	+	7
F	-	50730	+	12
G	+	2540	+	15
H	-	400	+	8
I	+	n.d.	-	7

Increase of IFN-γ secreting T-lymphocytes compared to baseline values before therapy. HAMA = human anti-mouse antibody reaction (values measured 4 weeks after trAb therapy).

ISSN: 1756-9966